Innovative Molecules Announces First Patient Dosed In Phase 2A Trial Of Adibelivir (IM-250), Advancing Company Into Late-Stage Clinical Development

(MENAFN - EQS Group) Innovative Molecules GmbH / Key word(s): Miscellaneous Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company ...